ABSTRACT
Introduction
Research instruments used
Data processing
Results
Discussion
Author: P. K. RUSTAGI, G. G. PRABHU, D. MOHAN, K. R. SUNDARAM
Pages: 33 to 40
Creation Date: 1981/01/01
The total sample size for the study of intrapsychic variables was 252 (152 non-drug users and 100 life-time users including 69 current users). Using a multiphasic personality questionnaire, the Eysenck personality inventory and an orientation questionnaire, the authors found that high orientation, extraversion, anxiety and psychopathic deviate scores were associated with a relative risk of drug use. No significant difference is reported between the mean scores of users and non-users on mania, paranoia, depression, schizophrenia, hysteria and neuroticism.
Part I of this study described the relative risk of drug abuse associated with some socio-demographic and interpersonal variables [ 1] . Part II describes the results of the study of intrapsychic variables. The total sample size for the study of intrapsychic variables was 252 (152 non-users, 100 lifetime users, of whom 69 were current users). Operational definitions, sampling procedure and method of test administration were outlined in Part I.
. Multiphasic personality questionnaire (MPQ). A self-administered questionnaire standardized in India on MMPI pattern [ 2] , [ 3] , [ 4] , [ 5] , [ 6] with seven clinical scales (mania, paranoia, depression, schizophrenia, anxiety, hysteria and psychopathic deviate) and one validation scale (K).
Eysenck personality inventory (EPI). Applied with minor modification for use in India [ 7] .
Orientation questionnaire. In Likert [ 8] format with seven opinion statements about drug use.
Data regarding each scale of the above-mentioned tests were analysed separately to find whether the mean score of non-users was significantly different from that of current users and life-time users.
Variables in which significant differences were found on one or both of these comparisons were subjected to further analysis. For each of these variables, the total sample median was calculated. Using this (the nearest whole number) as the dividing line, all participants were divided into low and high scorers. Relative risk of current use and life-time use associated with a high score on each of these variables was computed.
In the case of M PQ, besides the eight conventional scales, the sum of the scores on the seven clinical scales was taken as a separate variable and called "total psychopathology".
Significance level in the above-mentioned calculation was taken at p < 0.05.
Orientation. Table 1 shows that there was a significant difference between the mean orientation score of non-users and users. Relative risk of current use for high scorers was 1.83 while that of life-time use was 1.47.
Non-users (NU) |
Current users (CU) |
Life-time users (LU) a |
|
---|---|---|---|
Mean
|
12.29 | 14.23 | 14.02 |
S.E.
|
0.33 | 0.51 | 0.45 |
NU vs. CU
|
NU vs. LU
|
||
t = 3.27
|
t = 2.44
|
||
p<0.01
|
p<0.01
|
||
Total sample median = 11.68
|
|||
Score
|
Non-users
|
Current users
|
Life-time users
|
≤12
|
89 | 26 | 43 |
>12
|
61 | 43 | 56 |
Relative risk of current use = 1.83
|
|||
χ2=8.04
|
p<0.01
|
||
Relative risk of life-time use = 1.47
|
|||
χ2=5.43
|
p<0.05
|
Eysenck personality inventory. While the mean extraversion scores of users were significantly higher than non-users (table 2), no such difference was observed for the lie and neuroticism scales. Relative risk with respect to higher scores on extraversion was 2.06 for current use and 1.70 for life-time use.
Table 2 Extraversion scores
Non-users (NU) |
Current users (CU) |
Life-time users (LU) a |
|
---|---|---|---|
Mean
|
10.78 | 13.03 | 12.82 |
S.E.
|
0.32 | 0.54 | 0.45 |
NU vs. CU
|
NU vs. LU
|
||
t=3.72
|
t=3.77
|
||
p<0.001
|
p<0.001
|
||
Total sample median = 11.04
|
|||
Score
|
Non-users
|
Current users
|
Life-time users
|
≤11
|
89 | 23 | 37 |
>11
|
63 | 46 | 63 |
Relative risk of current use =2.06
|
|||
χ2 = 11.09
|
p <0.01
|
||
Relative risk of life-time use = 1.70
|
|||
χ2 = 10.36
|
p <0.01
|
Multiphasic personality inventory. Current users and life-time users scored significantly higher than non-users on the anxiety and psychopathic deviate scales, as well as the total psychopathology score (tables 3, 4 and 5). Relative risk for higher scores on the anxiety scale was 1.67 for current use and 1.40 for life-time use. Higher scores were obtained in respect of the psychopathic deviate scale. Relative risk of current use was 1.93 and that of life-time use was 1.78. With higher total psychopathology scores, relative risk of current use was 1.70 and that of life-time use was 1.35.
Table 3 Anxiety scores
Non-users (NU) |
Current users (CU) |
Life-time users (LU) a |
|
---|---|---|---|
Mean
|
7.03 | 8.99 | 7.83 |
S.E.
|
0.26 | 0.41 | 0.34 |
NU vs. CU
|
NU vs. LU
|
||
t= -2.19
|
t= -1.88
|
||
p<0.05
|
Not significant
|
||
Total sample median=6.33
|
|||
Score
|
Non-users
|
Current users
|
Life-time users
|
≤6
|
80 | 24 | 39 |
>6
|
72 | 45 | 61 |
Relative risk of current use = 1.67
|
|||
χ2 =5.37
|
p < 0.05
|
||
Relative risk of life-time use = 1.40
|
|||
χ2 =3.96
|
p < 0.05
|
Non-users (NU) |
Current users (CU) |
Life-time users (LU) a |
|
---|---|---|---|
Mean
|
10.78 | 12.33 | 12.33 |
S.E.
|
0.27 | 0.41 | 0.38 |
NU vs. CU
|
NU vs. LU
|
||
t =3.18
|
t =3.40
|
||
p < 0.01
|
p < 0.001
|
||
Total sample median = 10.5
|
|||
Score
|
Non-users
|
Current users
|
Life-time users
|
≤10
|
83 | 22 | 32 |
>10
|
69 | 47 | 68 |
Relative risk of current use = 1.93
|
|||
χ2= 8.93
|
p < 0.01
|
||
Relative risk of life-time use = 1.78
|
|||
χ2= 11.53
|
p < 0.001
|
Non-users (NU) |
Current users (CU) |
Life-time users (LU) a |
|
---|---|---|---|
Mean
|
36.23 | 40.46 | 39.88 |
S.E.
|
1.05 | 1.56 | 1.35 |
NU vs. CU
|
NU vs. LU
|
||
t = 2.25
|
t = 2.14
|
||
p < 0.05
|
p < 0.05
|
||
Total sample median = 34.50
|
|||
Score
|
Non-users
|
Current users
|
Life-time users
|
≤34
|
81 | 24 | 41 |
>34
|
71 | 45 | 59 |
Relative risk of current use = 1.70
|
|||
χ2= 5.80
|
p < 0.05
|
||
Relative risk of life-time use = 1.35
|
|||
χ2= 3.17
|
Not significant
|
There was no significant difference between the mean scores of users and non-users on mania, paranoia, depression, schizophrenia, hysteria and K scales of MPQ.
Test-retest reliability at three months' interval (N= 25)
Correlation co-efficient (r) was 0.50 (p < 0.001) for the orientation scale, 0.66 (p<0.001) for the mania scale, 0.44 (p<0.05) for the paranoia scale, 0.40 (p < 0.05) for the depression scale, 0.58 (p < 0.001) for the schizophrenia scale, 0.75 (p<0.001) for the anxiety scale, 0.63 (p<0.001) for the psychopathic deviate scale, 0.19 (not significant) for the hysteria scale, 0.71 (p<0.001) for the K scale, 0.73 (p<0.001) for the total psychopathology score, 0.56 (p<0.001) for the extraversion scale, 0.74 (p<0.001) for the neuroticism scale and 0.61 (p<0.001) for the lie scale.
In assessing intrapsychic variables associated with drug abuse among high-school students, three self-administered questionnaires were used.
Drug abuse was found to be significantly associated with higher orientation scores. This finding is in line with some previous studies [ 9] , [ 10] , [ 11] but docs not agree with another [ 12] . In relation to this variable, relative risk of current use was 1.83 while that of life-time use was 1.47. Factors influencing adolescents' orientation to drug abuse could be many and could include attitudes and behaviour of friends and family members, childhood experiences and the mass media.
In the case of EPI, higher extraversion scores were associated with drug abuse. Relative risk associated with a higher level of extraversion was 2.06 for current use and 1.70 for life-time use. Studies with EPI and other similar inventories in the past [ 11] , [ 13] , [ 14] , [ 15] , [ 16] , [ 17] , [ 18] , [ 19] , [ 20] gave normal (similar to control group) or higher extraversion scores for drug abusers. No study to our knowledge has reported a lower extraversion score for a user population. The dimension of extraversion has been associated with activity, sociability, risk-taking behaviour and impulsivity. All these characteristics seemed to contribute to drug-abusing behaviour and participation in a drug-taking group. Mean scores on the neuroticism and lie scale did not distinguish users from nonusers. On reviewing earlier studies [ 11] , [ 13] , [ 14] , [ 15] [ 16] , [ 17] , [ 18] , [ 19] , [ 20] no consistent pattern emerged as far as the relationship between neuroticism and drug abuse was concerned. The score patterns on the lie scale indicate that deliberate faking, or response in terms of an ideal-self concept, was not significantly different as between users and non-users.
Among MPQ variables, anxiety, psychopathic deviate and total psychopathology scores showed significant differences between users and non-users. Earlier studies which used MMPI or MPQ [ 11] , [ 21] , [ 22] , [ 23] , [ 24] , [ 25] , [ 26] , [ 27] , [ 28] , [ 29] , [ 30] , [ 31] , [ 32] on drug abuse of various types reported diverse score profiles. However, most of them found a higher number of abnormal profiles among users, in particular with an elevation on the psychopathic deviate scale. Relative risk associated with higher anxiety scores was 1.67 for current use and 1.40 for life-time use. Findings on the anxiety scale were not similar to the neuroticism scale of EPI in the present study. This, in part, could be explained by the difference in the nature of these scales. While the anxiety scale is empirically constructed from items distinguishing anxiety neurotics from normal controls, the neuroticism scale is a factor analysis-based dimensional scale measuring anxiety traits with experimental neurophysiological validation. From the anxiety scale findings, one might hypothesize a relationship between drug abuse and a high-strung nature with low self-esteem.
Relative risk associated with a high score on the psychopathic deviate scale was 1.93 for current use and 1.78 for life-time use. This suggested that drug abuse could be taken as a form of deviant behaviour. In the current state of knowledge, the relative magnitude of environmental, genetic and existential factors in the causation of deviant behaviour is not quite clear.
Relative risk to drug abuse associated with a high total psychopathology score on MPQ was 1.70 for current use and 1.35 for life-time use. This was consistent with the findings of various investigators indicating a higher percentage of abnormal MMPI profiles in people indulging in drug abuse. Tile absence of significant differences oil tile K scale has similar implications as suggested for the EPI lie scale.
The variables in descending order of magnitude of relative risk were extraversion, psychopathic deviate, orientation to drug use, total psychopathology and anxiety. In the case of all these variables, relative risk of lifetime use was less than that of current use. This suggests the role of these variables not only in initiating drug abuse but also in maintaining it. Test-retest reliability at a three-month interval has been expressed in terms of correlation co-efficient which is significant in the case of all scales except the hysteria scale of MPQ.
The association discussed above could be of use at all levels of prevention, for example, providing alternative activities (physical, recreational, social) for extraverted students. These activities would hopefully prevent extraverted non-users from experimenting with drugs, help extraverted users abstain from their use and prevent extraverted past users from returning to drug Use. The anxiety-prone could be helped by counselling services while deviants could be helped by corrective education.
D. Mohan and others, "Relative risk of adolescent drug abuse; Part 1: Sociodemographic and interpersonal variables, Bulletin on Narcotics, vol. 33, No. 1 (1980).
002C. S. Lakshminarayan and H. N. Murthy, "Development of K scale", Transactions of the All India Institute of Mental Health, vol. 10, 1970, p. 127.
003C. S. Lakshminarayan, K. Sathyavathi and H. N. Murthy, "Towards the development of the psychopathic deviate scale", Transactions of the All India Institute of Mental Health, vol. 9, 1969, p. 81.
004H. N. Murthy, "Development and validation of a schizophrenia scale", Transactions of the All India Institute of Menthal Health , vol. 4, 1964, p. 1.
005H.N. Murthy, "Development of the paranoia, depression, mania and anxiety scales", Transactions of the All India Institute of Mental Health , vol. 5, 1965, p. 50.
006H. N. Murthy and C. S. Lakshminarayan, "A note on the development of hysteria scale", Transactions of the All India Institute of Mental Health , vol. 8, 1968, p. 42.
007G. G. Prabhu, "Clinical utility of Eysenck personality inventory", Journal of Applied Psychology , vol. 1, 1970, p. 23.
008R. Likert, "A technique for the measurement of attitudes", Archives of Psychology , vol. 140, 1932, p. 1.
009R. Hartnoll and M. Mitcheson, "Attitudes of young people towards drug use", Bulletin on Narcotics , vol. 25, No. 2 (1973), p. 9.
010M. Kovacs, "A psychological approach toward the meanings of drug use", in Predicting Adolescent Drug Abuse: A Review of Issues, Methods and Correlates, D. J. Lettieri, ed. (Rockville, Maryland, National Institute of Drug Abuse, 1975).
011M.G. Thomas and others, "Personality and attitude correlates of drug abuse amongst students of a high school in Delhi: a replicated study", Indian Journal of Medical Research, vol. 69, 1979, p. 990.
012K. C. Dube and others, "Drug abuse among college students: an interim report", Bulletin on Narcotics, vol. 29, No. 1 (1977), p. 47.
013H.J. Eysenck and others, "Smoking and personality", British Medical Journal, vol. 1, 1960, p. 1456.
014C.M. Rosenberg, "Young drug addicts: background and personality", Journal of Nervous and Mental Disease, vol. 148, 1969, p. 65.
015H. Halsted and C. D. Neal, "Intelligence and personality in drug addicts", British Journal of Addiction, vol. 63, 1968, p. 237.
016S. Kanekar and A. Dolke, "Smoking, extraversion and neuroticism", Psychological Reports, vol. 26, 1970, p. 384.
017W. Buikuishan and H. Timmermann, "The development of drug taking among secondary school children in Netherlands", Bulletin on Narcotics, vol. 24, No. 3 (1972), p. 7.
018E. Hemminki, A. Rissanan and A. Mattila, "Drug use among school children in Helsinki - 1970", British Journal of Addiction, vol. 68, 1973, p. 159.
019J. E. Martin and J. Inglis, "Pain tolerance and narcotic addiction", British Journal of Social and Clinical Psychology, vol. 4, 1965, p. 224.
020G. Martin, "Social psychological correlates of drug use among Colombian university students", International Journal of the Addictions, vol. 11, 1976, p. 199.
021H.E. Hill, A. Haertzen and R. Glaser, "Personality characteristics of narcotic addicts as indicated by MMPI", Journal of General Psychology, vol. 62. 1960, p. 127.
022H.E. Hill, C. A. Haertzen and H. Davis, "An M.M.P.I. factor analytic study of alcoholics, narcotic addicts and criminals", Quarterly Journal of Studies on Alcohol, vol. 23, 1962, p. 421.
023R.W. Oslon, "M.M.P.I. sex differences in narcotic addicts", Journal of General Psychology, vol. 71, 1964, p. 257.
024J.J. Munroe, J. S. Miller and W. H. Lyle, Jr., "The extension of psychopathic deviate scale for screening of adult patients", Educational and Psychological Measurements, vol. 24, 1964, p. 47.
025D. N. Lombardi, B. J. O'Brien and F. W. Isele, "Differential responses of addicts and non addicts on MMPI", Journal of Projective Techniques and Personality Assessment, vol. 32, 1968, p. 479.
026C.P. McAcree, R. A. Staffenhagen and L. S. Zheutlin, "Personality factors in college drug users", International Journal of Social Psychiatry, vol. 15, 1969. p. 102.
027R.G. Smart and D. Fejer, "Illicit LSD users: their social backgrounds, drug use and psychopathology", Journal of Health and Social Behaviour, vol. 10, 1969, p. 249.
028P. Gendreau and L. P. Gendreau, "The 'addiction prone' personality: a study of Canadian heroin addicts", Canadian Journal of Behavioural Science, vol. 2, 1970, p. 18.
029C.P. McAcree, R. A. Staffenhagen and L. S. Zheutlin, "Personality factors and pattern of drug usage in college students", American Journal of Psychiatry, vol. 128, 1972, p. 890.
030E. Henriques and others, "Personality characteristics and drugs of choice", International Journal of Addictions, vol. 7, 1972, p. 73.
031J. Keller and D. C. Redfering, "Comparison between the personality of LSD users and non users as measured by the MMPI", Journal of Nervous and Mental Diseases, vol. 156, 1973, p. 271.
032R. Brook, K. Kaplum and P. C. Whitehead, "Personality characteristics of adolescents as measured by MMPI", British Journal of Addiction, vol. 69, 1974, p. 61.